Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Arrhythmias

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 39 articles: HTML format

Single Articles

March 2026
1. AGARWAL A, Ezekowitz J
   After cardioversion in AF, continued caffeinated coffee consumption vs. abstinence reduced AF or atrial flutter recurrence at 6 mo.
   Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-26-00131.
   PubMed     Abstract available
   
   
   February 2026
2. DAWWAS GK, Lewis JD, Tedla YG, Cuker A, et al
   The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol.
   Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-01408.
   PubMed     Abstract available
   
   
   
3. MUKHERJEE D
   In AF with drug-eluting stent for >/=1 y, NOACs were noninferior to NOAC + clopidogrel for a composite of adverse clinical events at 1 y.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05478.
   PubMed     Abstract available
   
   
   
4. SHARMA M, Srivastava A
   In patients with ischemic stroke, NVAF, and ASCVD, adding an antiplatelet to OAC therapy did not affect net clinical benefit at 2 y.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05308.
   PubMed     Abstract available
   
   
   January 2026
5. RUZIEH M
   In adults at high risk for ventricular arrhythmia, treatment to increase potassium to high-normal levels improved a composite outcome.
   Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-04843.
   PubMed     Abstract available
   
   
   
6. PAPAKONSTANTINOU PE, Lip GYH
   In symptomatic AF, nurse-led pre-ablation lifestyle treatment reduced repeat ablations or cardioversions at 1 y.
   Ann Intern Med. 2026;179:JC6.
   PubMed     Abstract available
   
   
   
7. WEITZ HH, Merli GJ, Lip G, Frisch D, et al
   Web Exclusive. Annals Consult Guys - Recurrent Atrial Fibrillation: The "Why?" and "When?" of "What to Do?".
   Ann Intern Med. 2026;179:e2600134CG.
   PubMed    
   
   
   November 2025
8. RUZIEH M
   In patients with AF and obesity, catheter ablation vs. lifestyle modification plus antiarrhythmic drugs improved AF freedom at 1 y.
   Ann Intern Med. 2025 Nov 4. doi: 10.7326/ANNALS-25-03844.
   PubMed     Abstract available
   
   
   
9. ITO K
   In older, frail, VKA-experienced patients with AF, SD-DOACs vs. warfarin reduced thrombotic events without increasing major bleeding.
   Ann Intern Med. 2025;178:JC128.
   PubMed     Abstract available
   
   
   September 2025
10. CENTOR RM, Zimetbaum P
    Annals On Call - Atrial Fibrillation: When Ablation Is the Way to Go.
    Ann Intern Med. 2025 Sep 2:e2503841OC. doi: 10.7326/ANNALS-25-03841.
    PubMed    
    
    
    August 2025
11. WEITZ HH, Merli GJ, Lip G
    Web Exclusive. Annals Consult Guys - Anticoagulation, Atrial Fibrillation, and Lower Gastrointestinal Bleeding.
    Ann Intern Med. 2025;178:e2503595CG.
    PubMed    
    
    
    July 2025
12. 
    Annals Video Summary - Catheter and Surgical Ablation for Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2025 Jul 1:e2502118VS. doi: 10.7326/ANNALS-25-02118.
    PubMed    
    
    
    
13. WAKS JW, Zimetbaum P
    The Significant Benefits of Ablation for Rhythm Control of Atrial Fibrillation.
    Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-02222.
    PubMed    
    
    
    
14. MONTANE B, Zhang S, Wolfe JD, Prime S, et al
    Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-00253.
    PubMed     Abstract available
    
    
    June 2025
15. KATSANOS AH, Douketis JD
    In survivors of ICH with AF, DOACs reduced incident ischemic stroke and increased recurrent ICH at a median 1.4 y.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-01772.
    PubMed     Abstract available
    
    
    
16. OGUNTALA JO, Yan AT
    In AF with stable CAD, an OAC alone does not increase ischemic events and reduces major bleeding vs. OAC + SAPT at a mean 22 mo.
    Ann Intern Med. 2025;178:JC65.
    PubMed     Abstract available
    
    
    May 2025
17. ALBERTS MJ
    In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA.
    Ann Intern Med. 2025 May 6. doi: 10.7326/ANNALS-25-01330.
    PubMed     Abstract available
    
    
    
18. MANSOOR H, Elgendy IY
    In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 mo.
    Ann Intern Med. 2025;178:JC57.
    PubMed     Abstract available
    
    
    
19. KHATTAK S, Al-Ansari A, Alfaraidhy M, Rajah F, et al
    Cardiology: What You May Have Missed in 2024.
    Ann Intern Med. 2025;178.
    PubMed     Abstract available
    
    
    April 2025
20. ABDEL-QADIR H, Gunn M, Fang J, Odugbemi T, et al
    Risk for Stroke After Newly Diagnosed Atrial Fibrillation During Hospitalization for Other Primary Diagnoses : A Retrospective Cohort Study.
    Ann Intern Med. 2025 Apr 22. doi: 10.7326/ANNALS-24-01967.
    PubMed     Abstract available
    
    
    
21. PATEL NS, Joglar JA
    A New Perspective on Atrial Fibrillation "Provoked" by Hospitalization.
    Ann Intern Med. 2025 Apr 22. doi: 10.7326/ANNALS-25-01073.
    PubMed    
    
    
    March 2025
22. LADER EW
    In previous MI with ventricular tachycardia (VT), catheter ablation reduced mortality or VT events more than antiarrhythmic drug therapy at 4 y.
    Ann Intern Med. 2025 Mar 4. doi: 10.7326/ANNALS-25-00336.
    PubMed     Abstract available
    
    
    February 2025
23. SMETANA GW, Gelfand EV, Tung P, Burns RB, et al
    How Would You Manage This Patient With Recent-Onset Atrial Fibrillation? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2025 Feb 11. doi: 10.7326/ANNALS-24-03490.
    PubMed     Abstract available
    
    
    
24. SHARMA M, Srivastava A
    In acute ischemic stroke with AF, early DOAC initiation was noninferior to delayed initiation for ischemic and hemorrhagic outcomes at 90 d.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03879.
    PubMed     Abstract available
    
    
    January 2025
25. BATES ER
    In subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y, regardless of duration of recent subclinical AF episodes.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03370.
    PubMed     Abstract available
    
    
    November 2024
26. ROMITI GF, Talerico G
    In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA(2)DS(2)-VASc >4.
    Ann Intern Med. 2024;177:JC125.
    PubMed     Abstract available
    
    
    July 2024
27. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
    Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
    Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
    PubMed     Abstract available
    
    
    
28. BARNES GD
    In device-detected AF, DOACs vs. aspirin or placebo reduce ischemic stroke and increase major bleeding.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00652.
    PubMed     Abstract available
    
    
    June 2024
29. WEITZ HH, Merli GJ, Lip GYH
    Annals Consult Guys - The ABCs of Atrial Fibrillation.
    Ann Intern Med. 2024;177:e2400618CG.
    PubMed    
    
    
    
30. FIELD TS
    In cryptogenic stroke and atrial cardiopathy, apixaban did not reduce recurrent stroke vs. aspirin.
    Ann Intern Med. 2024;177:JC65.
    PubMed     Abstract available
    
    
    May 2024
31. SPOSATO LA, Hill MD
    In AF, CHA(2)DS(2)-VASc 1 subgroups did not differ for predicting risk for arterial thromboembolism at 1 y.
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0023.
    PubMed     Abstract available
    
    
    
32. DUNN A
    In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo.
    Ann Intern Med. 2024;177:JC57.
    PubMed     Abstract available
    
    
    March 2024
33. SHADRIN IY, Newby LK
    In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y.
    Ann Intern Med. 2024;177:JC26.
    PubMed     Abstract available
    
    
    January 2024
34. ISHIGUCHI H, Lip GYH
    In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 mo.
    Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0105.
    PubMed     Abstract available
    
    
    
35. LOPEZ J, Borzak S
    In noncardiac thoracic surgery, low-dose colchicine did not reduce AF or myocardial injury after noncardiac surgery at 14 d.
    Ann Intern Med. 2024;177:JC3.
    PubMed     Abstract available
    
    
    December 2023
36. BROPHY J
    In symptomatic AF with end-stage HF, adding catheter ablation to medical therapy improved clinical outcomes at 18 mo.
    Ann Intern Med. 2023;176:JC137.
    PubMed     Abstract available
    
    
    October 2023
37. MCINTYRE WF, Vadakken ME, Connolly SJ, Mendoza PA, et al
    Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness : A Matched Cohort Study.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/M23-1411.
    PubMed     Abstract available
    
    
    
38. BARNES GD
    In adults, MRAs reduce AF occurrence vs. non-MRAs.
    Ann Intern Med. 2023;176:JC114.
    PubMed     Abstract available
    
    
    September 2023
39. TON IT, Moon J, Sengul A, Mody FV, et al
    Evidence-Based Cardiovascular Disease Medicines' Availability in Low-Cost Generic Drug Programs in the United States : A Cross-Sectional Study.
    Ann Intern Med. 2023 Sep 5. doi: 10.7326/M23-0287.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum